Man in violation of privacy law

Breaking news and expert analysis on legal and compliance issues

[Back To Home][Back To Archives]

From Antitrust Law Daily, February 11, 2019

Supplement marketers get warnings about health claims

By Jeffrey May, J.D.

The FTC and FDA have sent warning letters to companies that are purportedly marketing supplements as cures for Alzheimer’s disease and dementia.

Today, the FTC announced that, together with the U.S. Food and Drug Administration, it has notified three companies that they may be making false or unsubstantiated health claims in violation of the FTC Act for their supplements sold online. The letters were sent after the FDA conducted a review of the companies’ websites. In addition to the three letters jointly issued with the FTC, the FDA posted 12 warning letters and five online advisory letters, informing recipients that they are marketing unapproved new drugs and/or misbranded drugs that claim to prevent, treat, or cure Alzheimer’s disease and a number of other serious diseases and health conditions and that these products have been sold in violation of the Federal Food, Drug, and Cosmetic Act.

The joint FTC/FDA letters were sent to Gold Crown Natural ProductsTEK Naturals, and Pure Nootropics. These companies were instructed to contact the FTC within 15 days regarding actions taken to address the agency’s concerns. The FTC can bring civil enforcement actions against companies deceptively promoting, marketing, or selling health-related products and seek monetary redress for consumers, according to today's FTC announcement.

In the letters, the government explained that it is unlawful under the FTC Act to advertise that a product can prevent, treat, or cure human disease without competent and reliable scientific evidence. The FTC expressed concern that the efficacy claims made by the firms were not properly substantiated.

Companies: Gold Crown Natural Products; Pure Nootropics, LLC; TEK Naturals

MainStory: TopStory Advertising ConsumerProtection FederalTradeCommissionNews

Back to Top

Antitrust Law Daily

Introducing Wolters Kluwer Antitrust Law Daily — a daily reporting service created by attorneys, for attorneys — providing same-day coverage of breaking news, court decisions, legislation, and regulatory activity.

A complete daily report of the news that affects your world

  • View full summaries of federal and state court decisions.
  • Access full text of legislative and regulatory developments.
  • Customize your daily email by topic and/or jurisdiction.
  • Search archives for stories of interest.

Not just news — the right news

  • Get expert analysis written by subject matter specialists—created by attorneys for attorneys.
  • Track law firms and organizations in the headlines with our new “Who’s in the News” feature.
  • Promote your firm with our new reprint policy.

24/7 access for a 24/7 world

  • Forward information with special copyright permissions, encouraging collaboration between counsel and colleagues.
  • Save time with mobile apps for your BlackBerry, iPhone, iPad, Android, or Kindle.
  • Access all links from any mobile device without being prompted for user name and password.